Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells

被引:59
作者
Gomez-Bougie, P [1 ]
Bataille, R [1 ]
Amiot, M [1 ]
机构
[1] Inst Biol, UMR601, INSERM, UMR601,Dept Rech Cancerol,Equipe Labelisee LNC 5, F-44093 Nantes, France
关键词
human B cells; BH3-only Bim; Mcl-1; Bcl-2;
D O I
10.1002/eji.200425878
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bim is an essential regulator of lymphoid system homeostasis and appears essential for B cell apoptosis induction. The mechanism by which Bim isoforms are held in an inactive form remains poorly documented in normal B cells. In the current study, we demonstrated that in normal tonsil B cells the three major Bim isoforms are strongly associated with the anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2 and Bcl-x(L). On the other hand, only a weak association of BimEL and L with the dynein LC8 chain has been found. In addition, there is no free Bim in normal B cells. Moreover, subcellular fractionation demonstrated that Bim and the anti-apoptotic counterparts are localized preferentially in the mitochondria-rich fraction. The fact that most Bim was found in this fraction supports the hypothesis that it is sequestered by anti-apoptotic molecules in mitochondria where its pro-apoptotic activity is controlled. Of interest, BimS is essentially complexed to Mcl-1 and the Mcl-1/Bim complex is the most abundant among the three types of complexes. This supports the idea that this complex is critical for the control of B cell death. In conclusion, these results favor a model in which Bim release from anti-apoptotic proteins is a critical event for initiation of apoptosis.
引用
收藏
页码:971 / 976
页数:6
相关论文
共 27 条
  • [1] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [2] BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes
    Bouillet, P
    Purton, JF
    Godfrey, DI
    Zhang, LC
    Coultas, L
    Puthalakath, H
    Pellegrini, M
    Cory, S
    Adams, JM
    Strasser, A
    [J]. NATURE, 2002, 415 (6874) : 922 - 926
  • [3] Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells
    Enders, A
    Bouillet, P
    Puthalakath, H
    Xu, YK
    Tarlinton, DM
    Strasser, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) : 1119 - 1126
  • [4] The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells
    Gomez-Bougie, P
    Bataille, R
    Amiot, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) : 3156 - 3164
  • [5] BCL-2 family members and the mitochondria in apoptosis
    Gross, A
    McDonnell, JM
    Korsmeyer, SJ
    [J]. GENES & DEVELOPMENT, 1999, 13 (15) : 1899 - 1911
  • [6] Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim
    Hildeman, DA
    Zhu, YN
    Mitchell, TC
    Bouillet, P
    Strasser, A
    Kappler, J
    Marrack, P
    [J]. IMMUNITY, 2002, 16 (06) : 759 - 767
  • [7] BOD (Bcl-2-Related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members
    Hsu, SY
    Lin, P
    Hsueh, AJW
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (09) : 1432 - 1440
  • [8] BH3-Only proteins - Essential initiators of apoptotic cell death
    Huang, DCS
    Strasser, A
    [J]. CELL, 2000, 103 (06) : 839 - 842
  • [9] Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membrane
    Kaufmann, T
    Schlipf, S
    Sanz, J
    Neubert, K
    Stein, R
    Borner, C
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 160 (01) : 53 - 64
  • [10] Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
    Letai, A
    Bassik, MC
    Walensky, LD
    Sorcinelli, MD
    Weiler, S
    Korsmeyer, SJ
    [J]. CANCER CELL, 2002, 2 (03) : 183 - 192